- What are the odds for "Will CRISPR Therapeutics (CRSP) beat quarterly earnings?" on Polymarket?
- Polymarket traders currently price it at Yes 65% · No 36%. Polymarket prices are implied probabilities: a share that pays $1 if the outcome happens trades at its probability in cents. Resolves by Nov 4, 2026.
- Who is the smart money on "Will CRISPR Therapeutics (CRSP) beat quarterly earnings?"?
- Polynyx ranks every Polymarket wallet by realized profit and consistency and shows which side the ranked wallets hold on this market, their average entry and how much they have invested. Premium opens every smart wallet by name, with its P&L and full trade history.
- How much has been traded on "Will CRISPR Therapeutics (CRSP) beat quarterly earnings?"?
- 24h volume $150, liquidity $513, $275 traded all-time. Volume and liquidity come straight from Polymarket; Polynyx adds the holder book, the live trade tape and whale-size flags on each trade.
- Can I build my own dashboard for "Will CRISPR Therapeutics (CRSP) beat quarterly earnings?"?
- Yes. Polydune turns this market into a no-code dashboard — odds over time, smart money by side, holders and the tape as widgets you arrange yourself — and keeps it live from the same Polynyx data. Open the market on Polydune and use the template.